School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY.
Department of Dermatology, University of Rochester Medical Center, Rochester, NY.
J Allergy Clin Immunol Pract. 2020 Mar;8(3):860-875. doi: 10.1016/j.jaip.2019.12.005.
Atopic dermatitis (AD) is one of the most common inflammatory skin conditions, affecting 15% to 30% of children and 2% to 10% of adults. Population-based studies suggest that having AD is associated with subsequent development of other atopic diseases, in what is known as the "atopic march." We will provide an overview of studies that investigate primary prevention strategies for the first 2 diseases in the march, namely, AD and food allergies (FA). These strategies include emollients, breastfeeding, microbial exposures, probiotics, vitamin D and UV light, water hardness, and immunotherapy. Some studies, including randomized controlled trials on emollients and microbial supplementation, have found encouraging results; however, the evidence remains limited and contradictory. With regard to breastfeeding, microbial and lifestyle exposures, vitamin D and UV light, water hardness, and immunotherapy, the lack of randomized controlled trials makes it difficult to draw definitive conclusions. Current American Academy of Pediatrics guidelines support the idea that breastfeeding for 3 to 4 months can decrease AD incidence in children less than 2 years old. Recommendations regarding a direct relationship between breastfeeding on FA, however, cannot be made because of insufficient data. Regarding microbial supplementation, most guidelines do not recommend probiotics or prebiotics for the purpose of preventing allergic diseases because of limited evidence. Before definitive conclusions can be made regarding these interventions, more well-designed, longitudinal, and randomized controlled trials, particularly in at-risk populations, are required.
特应性皮炎(AD)是最常见的炎症性皮肤病之一,影响 15%至 30%的儿童和 2%至 10%的成年人。基于人群的研究表明,患有 AD 与随后发生其他特应性疾病有关,这被称为“特应性进行曲”。我们将概述研究特应性进行曲中前两种疾病的一级预防策略,即 AD 和食物过敏(FA)。这些策略包括保湿剂、母乳喂养、微生物暴露、益生菌、维生素 D 和 UV 光、水硬度和免疫疗法。一些研究,包括关于保湿剂和微生物补充的随机对照试验,已经发现了令人鼓舞的结果;然而,证据仍然有限且相互矛盾。关于母乳喂养、微生物和生活方式暴露、维生素 D 和 UV 光、水硬度和免疫疗法,由于缺乏随机对照试验,很难得出明确的结论。目前,美国儿科学会指南支持母乳喂养 3 至 4 个月可以降低 2 岁以下儿童 AD 发病率的观点。然而,由于数据不足,关于母乳喂养与 FA 之间直接关系的建议无法提出。关于微生物补充,由于证据有限,大多数指南不建议使用益生菌或益生元来预防过敏性疾病。在对这些干预措施得出明确结论之前,需要进行更多设计良好、纵向和随机对照试验,特别是在高危人群中。